Figure 6.
IEGPI score for immunotherapy response prediction. (A–E) IEGPI score’s potential as a tool for immunotherapy response prediction in melanoma, bladder cancer, and lung cancer; (F) the distribution of IEGPI score in different immunotherapy response groups with both PD-1 and CTLA4 treatment; (G, H) Kaplan-Meier curves of patients with different IEGPI score.